- Home
- PGEN vs BCAL Comparison
PGEN vs BCAL Comparison
Compare PGEN & BCAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- BCAL
- Stock Information
- Founded
- PGEN 1998
- BCAL 2001
- Country
- PGEN United States
- BCAL United States
- Employees
- PGEN N/A
- BCAL N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- BCAL Major Banks
- Sector
- PGEN Health Care
- BCAL Finance
- Exchange
- PGEN Nasdaq
- BCAL Nasdaq
- Market Cap
- PGEN 493.0M
- BCAL 519.9M
- IPO Year
- PGEN N/A
- BCAL N/A
- Fundamental
- Price
- PGEN $4.18
- BCAL $16.87
- Analyst Decision
- PGEN Buy
- BCAL Buy
- Analyst Count
- PGEN 5
- BCAL 2
- Target Price
- PGEN $7.50
- BCAL $19.50
- AVG Volume (30 Days)
- PGEN 15.4M
- BCAL 106.1K
- Earning Date
- PGEN 08-12-2025
- BCAL 07-28-2025
- Dividend Yield
- PGEN N/A
- BCAL N/A
- EPS Growth
- PGEN N/A
- BCAL 15.70
- EPS
- PGEN N/A
- BCAL 0.99
- Revenue
- PGEN $4,340,000.00
- BCAL $157,669,000.00
- Revenue This Year
- PGEN $256.94
- BCAL $74.16
- Revenue Next Year
- PGEN $759.81
- BCAL $4.92
- P/E Ratio
- PGEN N/A
- BCAL $17.11
- Revenue Growth
- PGEN N/A
- BCAL 80.55
- 52 Week Low
- PGEN $0.65
- BCAL $11.87
- 52 Week High
- PGEN $4.21
- BCAL $18.49
- Technical
- Relative Strength Index (RSI)
- PGEN 88.14
- BCAL 68.89
- Support Level
- PGEN $2.94
- BCAL $15.86
- Resistance Level
- PGEN $3.34
- BCAL $16.44
- Average True Range (ATR)
- PGEN 0.32
- BCAL 0.40
- MACD
- PGEN 0.22
- BCAL 0.13
- Stochastic Oscillator
- PGEN 99.00
- BCAL 91.52
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.